Literature DB >> 3102676

Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion.

M L Dustin, M E Sanders, S Shaw, T A Springer.   

Abstract

CD2 is a T lymphocyte glycoprotein that functions in adhesion of T lymphocytes and also as a putative receptor for activation signals. Functional data suggest that LFA-3, a widely distributed cell surface glycoprotein, may be the biological ligand of CD2. We have purified LFA-3 from human erythrocytes and characterized the purified protein functionally. LFA-3 bound specifically to CD2+ cells, and this binding was inhibited by CD2 mAb. Conversely, purified LFA-3 inhibited binding of CD2 mAb to cells, and the concentration required for this effect suggests that LFA-3 half-saturated CD2 at 1-5 nM LFA-3. Purified LFA-3 inhibited rosetting of human and sheep erythrocytes with CD2+ T lymphoma cells and T lymphocytes, and mediated aggregation of a CD2+ T lymphoma cell line. Purified LFA-3 reconstituted into planar membranes mediated efficient CD2-dependent adhesion of T lymphoblasts. These data demonstrate that LFA-3 is a ligand for CD2 and that LFA-3 can mediate T lymphocyte adhesion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102676      PMCID: PMC2188278          DOI: 10.1084/jem.165.3.677

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Sialic acids and sialyltransferases in murine lymphoid cells: indicators of T cell maturation.

Authors:  J P Despont; C A Abel; H M Grey
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Specific properties of human B and T lymphocytes and alterations in disease.

Authors:  Z Bentwich; H G Kunkel
Journal:  Transplant Rev       Date:  1973

4.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

5.  Detergent solubilization, purification, and separation of specificities of HLA antigens from a cultured human lymphoblastoid line, RPMI 4265.

Authors:  T A Springer; D L Mann; A L DeFranco; J L Strominger
Journal:  J Biol Chem       Date:  1977-07-10       Impact factor: 5.157

6.  Cytotoxic T cells generated in the autologous mixed lymphocyte reaction. I. Primary autologous mixed lymphocyte reaction.

Authors:  K Tomonari
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

7.  Rosetting of human red blood cells to thymocytes and thymus-derived cells.

Authors:  G Baxley; G B Bishop; A G Cooper; H H Wortis
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

8.  Temperature and compositional dependence of the structure of hydrated dimyristoyl lecithin.

Authors:  M J Janiak; D M Small; G G Shipley
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3).

Authors:  M L Plunkett; M E Sanders; P Selvaraj; M L Dustin; T A Springer
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  68 in total

1.  Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies.

Authors:  Z Y Sun; V Dötsch; M Kim; J Li; E L Reinherz; G Wagner
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

2.  Effect of lengthening lymphocyte function-associated antigen 3 on adhesion to CD2.

Authors:  P Y Chan; T A Springer
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

3.  New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues.

Authors:  D J Anstee; B Gardner; F A Spring; C H Holmes; K L Simpson; S F Parsons; G Mallinson; S M Yousaf; P A Judson
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

4.  Functional properties of human lamina propria T lymphocytes assessed with mitogenic monoclonal antibodies.

Authors:  L Qiao; G Schürmann; M Betzler; S C Meuer
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 5.  Modular design of immunological synapses and kinapses.

Authors:  Michael L Dustin
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-07       Impact factor: 10.005

Review 6.  Cell adhesion molecules and actin cytoskeleton at immune synapses and kinapses.

Authors:  Michael L Dustin
Journal:  Curr Opin Cell Biol       Date:  2007-10-17       Impact factor: 8.382

7.  Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding.

Authors:  E Parra; M Varga; G Hedlund; T Kalland; M Dohlsten
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

8.  Restricted expression of CD2 among subsets of sheep thymocytes and T lymphocytes.

Authors:  G W Giegerich; W R Hein; M Miyasaka; G Tiefenthaler; T Hünig
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

Review 9.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

10.  Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils.

Authors:  C A Parkos; S P Colgan; M S Diamond; A Nusrat; T W Liang; T A Springer; J L Madara
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.